Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China
about
Clinical relevance and public health significance of hepatitis B virus genomic variationsCancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesisOverview of hepatitis B virus mutations and their implications in the management of infectionDNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma.Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.The association between hepatitis B mutants and hepatocellular carcinoma: A meta-analysisVirus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Viral hepatocarcinogenesis.Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong, China.Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach.TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations.Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.Hepatitis B virus infection and the risk of hepatocellular carcinoma.DNA markers in molecular diagnostics for hepatocellular carcinoma.Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya.TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The GambiaQuantitative evaluation of hepatitis B virus mutations and hepatocellular carcinoma risk: a meta-analysis of prospective studies.Effects of genomic changes in hepatitis B virus on postoperative recurrence and survival in patients with hepatocellular carcinoma.Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and womenMolecular characteristics and stages of chronic hepatitis B virus infectionBiomarkers in population studies: environmental mutagenesis and risk for cancer.HCC-Associated Single Nucleotide Variants and Deletions Identified Using Genome-Wide High Throughput Analysis of HBV.Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival.Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China.Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China.Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.Genetic variations of hepatitis B virus and serum aflatoxin-lysine adduct on high risk of hepatocellular carcinoma in Southern Guangxi, China.Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan.Clinical and virological implications of A1846T and C1913A/G mutations of hepatitis B virus genome in severe liver diseases.
P2860
Q24644176-99B56631-3DAA-448C-836E-CA0027084786Q26766386-9ACF5A7F-E0D1-478B-AA4A-D7BB7FE3116FQ26772346-F38649A1-0B64-4B4B-8162-6BBB7EF3CF26Q27336155-FEED9072-B3E8-4294-BEE0-0B4A35DFCB84Q33553814-1AF5CBFE-A2D3-45F4-BBD6-8A23445D08C3Q33661054-2655FCAC-8F29-4F9F-9B67-417EFFA7C05BQ33672710-E06A0A20-1100-40CB-9372-C529DBA4F279Q33723810-4825F1F7-9ACB-4455-9A7C-0C063EA3855AQ34617749-CA2F46F5-2058-438E-B26F-2A6963CBF808Q35020474-BA0ABABD-3F0B-42F4-BD9E-D88F78B50612Q35140069-1B168843-506E-41C0-8C52-DB6679C76423Q35173311-384FA7F3-572A-4EB2-AF50-396E0134EFF8Q35507447-F1463537-6D7D-402F-BA95-2AECBC246A06Q35579913-6F3134AE-4AB0-423B-A0E8-00B671984221Q35606904-00CF5AB2-0011-4887-9D29-283CF81B8008Q35781255-AF502093-6C47-47FD-97F2-1CE44F71DD05Q35942328-C9D49717-F0C0-48F2-8145-693E7024701EQ36072589-A6E709BC-F7DF-47BD-AD46-790DDB65C0FAQ36227142-F8BCF81D-6539-46EC-A4A7-4E87694459C6Q36698843-0524347A-019C-4FF3-BB4C-07BBB64DF7C1Q36801410-D834B2D0-6B70-45EC-A82B-EF5193CB5950Q37176658-7FFCD35C-9415-4AA7-9591-3B25A8894CC4Q37250341-8E75A1F9-1DA1-4758-8C66-A988484FEB7BQ37573672-1AAE776F-D0C3-43CD-B943-BC29660BF10FQ39428108-0B80C0BA-AB35-4716-88AE-B54C4F266AFFQ39570667-677F9F8C-454E-43E3-8037-81B934EC4A17Q40803630-8EE7CE4A-5C1F-41C4-BFD7-C412FA1D1F37Q41882762-E2546682-E2E7-401C-A531-B138E5CA9BF2Q42248914-7215E170-A809-4B5B-8CDE-DFA99DB2A18FQ42263074-FC2187E6-38C6-4F4E-9586-FD3D66609595Q42436025-17DC70BC-BF9C-41F4-99A6-5495D1170DD6Q42962258-678FD232-FF60-446A-B8BC-FAC591E7FB2CQ42967810-C71DE528-6D91-4E9A-A14F-BEA787FB0FAFQ45373255-E5667A19-4390-41C1-83A3-87EE6B42AE01Q47555493-36AD76D3-5A44-4E6D-8A1D-563FF1BAF272
P2860
Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prospective evaluation of hepa ...... development in Shanghai, China
@en
Prospective evaluation of hepa ...... evelopment in Shanghai, China.
@nl
type
label
Prospective evaluation of hepa ...... development in Shanghai, China
@en
Prospective evaluation of hepa ...... evelopment in Shanghai, China.
@nl
prefLabel
Prospective evaluation of hepa ...... development in Shanghai, China
@en
Prospective evaluation of hepa ...... evelopment in Shanghai, China.
@nl
P2093
P2860
P1476
Prospective evaluation of hepa ...... development in Shanghai, China
@en
P2093
Alex Ambinder
John D Groopman
Yunhua Fan
P2860
P304
P356
10.1158/1055-9965.EPI-08-0966
P577
2009-02-03T00:00:00Z